SCHEMBL950991

SCHEMBL950991

Cc1ccc2c(c1)COC(c1cc(C(F)(F)F)nn1-c1ncccc1Cl)=[N+]2[O-]

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.36
▸ OPRL1 P41146 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PTGS2 P35354 7/20 0.34
▸ PTGS1 P23219 6/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CYP2C9 P11712 2/20 0.33
▸ PTGES O14684 2/20 0.33
▸ PDPK1 O15530 2/20 0.33
▸ NR3C2 P08235 2/20 0.33
▸ ALOX5 P09917 2/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ PDE5A O76074 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ MT-CO2 P00403 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1468494 0.93 KDM4E (0.36) HSD11B1OPRL1KDM4EMEN1ALDH1A1
SCHEMBL950060 0.91 PTGS2 (0.36) HSD11B1OPRL1KDM4EMEN1ALDH1A1
SCHEMBL952345 0.88 KDM4E (0.37) HSD11B1OPRL1KDM4EMEN1ALDH1A1
SCHEMBL950412 0.87 OPRL1 (0.35) HSD11B1OPRL1KDM4EMEN1ALDH1A1
SCHEMBL952307 0.85 OPRL1 (0.34) HSD11B1OPRL1KDM4EMEN1ALDH1A1
SCHEMBL951621 0.84 OPRL1 (0.35) OPRL1KDM4EMEN1ALDH1A1MAPT
SCHEMBL952103 0.84 KDM4E (0.36) HSD11B1OPRL1KDM4EMEN1ALDH1A1
SCHEMBL954789 0.82 KDM4E (0.35) HSD11B1OPRL1KDM4EMEN1ALDH1A1
SCHEMBL952893 0.80 KDM4E (0.33) OPRL1KDM4EMEN1ALDH1A1MAPT
SCHEMBL950738 0.80 PTGS2 (0.33) OPRL1KDM4EMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968573-B2 Hydrazide compound and pesticidal use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-28 — — US disclosed
EP-1937664-B1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME SUMITOMO CHEMICAL CO (JP) 2011-06-15 — — EP disclosed
US-20110071291-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME IKEGAMI HIROSHI 2011-03-24 — — US disclosed
US-7867949-B2 Hydrazide compound and pesticidal use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-01-11 — — US disclosed
EP-2251336-A1 Hydrazide compounds as intermediates of pesticides Sumitomo Chemical Company, Limited (JP) 2010-11-17 — — EP disclosed
US-20090181956-A1 Hydrazide Compound and Pesticidal Use of the Same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-16 — — US disclosed
EP-1937664-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME Sumitomo Chemical Company, Limited (JP) 2008-07-02 — — EP disclosed
WO-2007043677-A9 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME SUMITOMO CHEMICAL CO (JP) 2007-06-07 — — WO disclosed
WO-2007043677-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071291-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME ACHE, H1-2, H1-0 HSD11B1 1797/4885OPRL1 3235/4885KDM4E 1084/4885
US-20090181956-A1 Hydrazide Compound and Pesticidal Use of the Same ACHE, DDT, CAT HSD11B1 651/4885OPRL1 3704/4885KDM4E 2028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback